The memo above was sent out only three days before Pfizer made the following announcement:
Broad Access Program for Patients with Limited Available Treatment Options
NEW YORK - Pfizer announced today that it plans to establish a multi-national Expanded Access Program (EAP) to make the investigational CCR5 antagonist maraviroc, currently in ongoing phase 3 clinical trials, available to HIV/AIDS patients with CCR5-tropic HIV-1 who have limited or no approved treatment options due to resistance or intolerance. Pending regulatory review and approvals of the EAP study protocol, the program will begin enrolling patients in the next few months, with a target to enroll patients from over 30 countries.
More here.
--------------------------------------------------------------------------------------
And here's the next memo telling us about the "naïve doctors":
From: Fitzgerald, Kelly
Sent: Thursday, November 16, 2006 6:20 PM
To: DL-USPFF-SM-HIV-SALES-TSR
Cc: Rodriguez, Arthur (Agouron); Brake, Jeffrey; McCarty, Gene; Mumford, Robert E; Traylor, Rhoyge W; Vollmers, Thomas L; Yost, John (La Jolla); Zaleski, Carolyn
Subject: Site Focus
HIV Sales Team,
As a follow up to all of you who have identified sites/physicians that are interested in clinical trials. Please double check that the mailing and contact information in Orion is correct. Information is beginning to be sent out to some sites and to ensure the interested parties receive the information the correct contact information needs to be in Orion. After you have answered all 8 questions there is no follow up required or expected on your part.
If anyone has additional research naïve sites and/or physicians that are interested please pass that information onto to Pamela Clax directly.
Thanks to everyone for helping move this project forward.
Kelly
Kelly Fitzgerald
National ASD - Pfizer HIV/AIDS
18500 Von Karman, Suite 600
Irvine, CA 92612
VM 800-8331838 Ext 81886
Cell (410) 409-7736
Office (949) 794-1506
Fax (949)794-1509
--------------------------------------------------------------------------------------
THESE TWO e-mails are pretty amazing. So here we have in black and white that Pfizer was looking for "research naïve doctors" WHICH MEANS DOCTORS WHO DIDN'T KNOW MUCH ABOUT RESEARCH!
Why, if Pfizer wanted GOOD research would they want such a thing?
Broad Access Program for Patients with Limited Available Treatment Options
NEW YORK - Pfizer announced today that it plans to establish a multi-national Expanded Access Program (EAP) to make the investigational CCR5 antagonist maraviroc, currently in ongoing phase 3 clinical trials, available to HIV/AIDS patients with CCR5-tropic HIV-1 who have limited or no approved treatment options due to resistance or intolerance. Pending regulatory review and approvals of the EAP study protocol, the program will begin enrolling patients in the next few months, with a target to enroll patients from over 30 countries.
More here.
And here's the next memo telling us about the "naïve doctors":
From: Fitzgerald, Kelly
Sent: Thursday, November 16, 2006 6:20 PM
To: DL-USPFF-SM-HIV-SALES-TSR
Cc: Rodriguez, Arthur (Agouron); Brake, Jeffrey; McCarty, Gene; Mumford, Robert E; Traylor, Rhoyge W; Vollmers, Thomas L; Yost, John (La Jolla); Zaleski, Carolyn
Subject: Site Focus
HIV Sales Team,
As a follow up to all of you who have identified sites/physicians that are interested in clinical trials. Please double check that the mailing and contact information in Orion is correct. Information is beginning to be sent out to some sites and to ensure the interested parties receive the information the correct contact information needs to be in Orion. After you have answered all 8 questions there is no follow up required or expected on your part.
If anyone has additional research naïve sites and/or physicians that are interested please pass that information onto to Pamela Clax directly.
Thanks to everyone for helping move this project forward.
Kelly
Kelly Fitzgerald
National ASD - Pfizer HIV/AIDS
18500 Von Karman, Suite 600
Irvine, CA 92612
VM 800-8331838 Ext 81886
Cell (410) 409-7736
Office (949) 794-1506
Fax (949)794-1509
--------------------------------------------------------------------------------------
THESE TWO e-mails are pretty amazing. So here we have in black and white that Pfizer was looking for "research naïve doctors" WHICH MEANS DOCTORS WHO DIDN'T KNOW MUCH ABOUT RESEARCH!
Why, if Pfizer wanted GOOD research would they want such a thing?
Next Page 1 | 2 | 3 | 4 | 5 | 6 | 7
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
